BCAS2 promotes primitive hematopoiesis by sequestering β-catenin within the nucleus

Area of Science:

• Developmental Biology
• Molecular Biology
• Hematopoiesis

Background:

• Breast carcinoma amplified sequence 2 (BCAS2) is a known RNA splicing regulator.
• Its non-splicing functions, particularly in development, are largely unexplored.
• Primitive hematopoiesis is a critical early developmental process.

Purpose of the Study:

• To investigate the role of BCAS2 in primitive hematopoiesis.
• To elucidate the molecular mechanism by which BCAS2 influences hematopoietic progenitor differentiation.
• To determine if BCAS2 has functions beyond RNA splicing in this context.

Main Methods:

• Depletion of BCAS2 in zebrafish embryos and mouse embryonic fibroblasts.
• Analysis of Wnt/β-catenin signaling pathway activation.
• Assessment of β-catenin pre-mRNA splicing and nuclear accumulation.
• Co-immunoprecipitation assays to detect direct binding of BCAS2 to β-catenin.

Main Results:

• BCAS2 depletion significantly impaired primitive hematopoiesis in zebrafish and mouse embryos.
• Wnt/β-catenin signaling activation was decreased upon BCAS2 depletion.
• BCAS2 deficiency did not affect β-catenin pre-mRNA splicing but reduced β-catenin nuclear accumulation.
• BCAS2 directly binds to β-catenin, promoting its nuclear retention.

Conclusions:

• BCAS2 is essential for primitive hematopoiesis.
• BCAS2 promotes Wnt/β-catenin signaling by enhancing β-catenin nuclear retention.
• This study uncovers a novel, non-splicing function of BCAS2 in regulating Wnt signaling during early development.